Log in to save to my catalogue

Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression—Case Series St...

Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression—Case Series St...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a6a56593cd854b829b9ab1a691faa7c5

Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression—Case Series Study

About this item

Full title

Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression—Case Series Study

Publisher

Basel: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2020-10, Vol.13 (10), p.326

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Bipolar disorder is a chronic and remitting mental illness. Antidepressants are not effective in treating acute bipolar depression, and antipsychotic drugs used in the treatment of bipolar depression cause frequent side effects. This situation justifies the search for new drugs as well as the repurposing of drugs used in other indications. In an op...

Alternative Titles

Full title

Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression—Case Series Study

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a6a56593cd854b829b9ab1a691faa7c5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a6a56593cd854b829b9ab1a691faa7c5

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph13100326

How to access this item